Literature DB >> 33322512

Notable Underlying Mechanism for Pancreatic β-Cell Dysfunction and Atherosclerosis: Pleiotropic Roles of Incretin and Insulin Signaling.

Hideaki Kaneto1, Atsushi Obata1, Tomohiko Kimura1, Masashi Shimoda1, Junpei Sanada1, Yoshiro Fushimi1, Naoto Katakami2, Takaaki Matsuoka2, Kohei Kaku3.   

Abstract

Under healthy conditions, pancreatic β-cells produce and secrete the insulin hormone in response to blood glucose levels. Under diabetic conditions, however, β-cells are compelled to continuously secrete larger amounts of insulin to reduce blood glucose levels, and thereby, the β-cell function is debilitated in the long run. In the diabetic state, expression levels of insulin gene transcription factors and incretin receptors are downregulated, which we think is closely associated with β-cell failure. These data also suggest that it would be better to use incretin-based drugs at an early stage of diabetes when incretin receptor expression is preserved. Indeed, it was shown that incretin-based drugs exerted more protective effects on β-cells at an early stage. Furthermore, it was shown recently that endothelial cell dysfunction was also associated with pancreatic β-cell dysfunction. After ablation of insulin signaling in endothelial cells, the β-cell function and mass were substantially reduced, which was also accompanied by reduced expression of insulin gene transcription factors and incretin receptors in β-cells. On the other hand, it has been drawing much attention that incretin plays a protective role against the development of atherosclerosis. Many basic and clinical data have underscored the importance of incretin in arteries. Furthermore, it was shown recently that incretin receptor expression was downregulated in arteries under diabetic conditions, which likely diminishes the protective effects of incretin against atherosclerosis. Furthermore, a series of large-scale clinical trials (SPAED-A, SPIKE, LEADER, SUSTAIN-6, REWIND, PIONEER trials) have shown that various incretin-related drugs have beneficial effects against atherosclerosis and subsequent cardiovascular events. These data strengthen the hypothesis that incretin plays an important role in the arteries of humans, as well as rodents.

Entities:  

Keywords:  atherosclerosis; incretin signaling; insulin signaling; pancreatic β-cell dysfunction

Year:  2020        PMID: 33322512      PMCID: PMC7763860          DOI: 10.3390/ijms21249444

Source DB:  PubMed          Journal:  Int J Mol Sci        ISSN: 1422-0067            Impact factor:   5.923


  68 in total

1.  Oral Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes.

Authors:  Mansoor Husain; Andreas L Birkenfeld; Morten Donsmark; Kathleen Dungan; Freddy G Eliaschewitz; Denise R Franco; Ole K Jeppesen; Ildiko Lingvay; Ofri Mosenzon; Sue D Pedersen; Cees J Tack; Mette Thomsen; Tina Vilsbøll; Mark L Warren; Stephen C Bain
Journal:  N Engl J Med       Date:  2019-06-11       Impact factor: 91.245

2.  Type 2 diabetes-a matter of beta-cell life and death?

Authors:  Christopher J Rhodes
Journal:  Science       Date:  2005-01-21       Impact factor: 47.728

3.  Endothelial insulin receptors differentially control insulin signaling kinetics in peripheral tissues and brain of mice.

Authors:  Masahiro Konishi; Masaji Sakaguchi; Samuel M Lockhart; Weikang Cai; Mengyao Ella Li; Erica P Homan; Christian Rask-Madsen; C Ronald Kahn
Journal:  Proc Natl Acad Sci U S A       Date:  2017-09-18       Impact factor: 11.205

4.  Sustained expression of GLP-1 receptor differentially modulates β-cell functions in diabetic and nondiabetic mice.

Authors:  Fumiyo Kubo; Takeshi Miyatsuka; Shugo Sasaki; Mitsuyoshi Takahara; Yuichi Yamamoto; Naoki Shimo; Hirotaka Watada; Hideaki Kaneto; Maureen Gannon; Taka-aki Matsuoka; Iichiro Shimomura
Journal:  Biochem Biophys Res Commun       Date:  2016-02-04       Impact factor: 3.575

5.  Effect of alogliptin, pioglitazone and glargine on pancreatic β-cells in diabetic db/db mice.

Authors:  Satoshi Kawashima; Taka-aki Matsuoka; Hideaki Kaneto; Yoshihiro Tochino; Ken Kato; Kaoru Yamamoto; Tsunehiko Yamamoto; Munehide Matsuhisa; Iichiro Shimomura
Journal:  Biochem Biophys Res Commun       Date:  2010-12-07       Impact factor: 3.575

6.  Identification of beta-cell-specific insulin gene transcription factor RIPE3b1 as mammalian MafA.

Authors:  Martin Olbrot; Jonathan Rud; Larry G Moss; Arun Sharma
Journal:  Proc Natl Acad Sci U S A       Date:  2002-05-14       Impact factor: 11.205

7.  MafA is critical for maintenance of the mature beta cell phenotype in mice.

Authors:  Wataru Nishimura; Satoru Takahashi; Kazuki Yasuda
Journal:  Diabetologia       Date:  2014-12-13       Impact factor: 10.122

Review 8.  Pancreatic β-cell glucose toxicity in type 2 diabetes mellitus.

Authors:  Hideaki Kaneto
Journal:  Curr Diabetes Rev       Date:  2015

9.  PDX-1 protein containing its own antennapedia-like protein transduction domain can transduce pancreatic duct and islet cells.

Authors:  Hirofumi Noguchi; Hideaki Kaneto; Gordon C Weir; Susan Bonner-Weir
Journal:  Diabetes       Date:  2003-07       Impact factor: 9.461

10.  Rationale, design, and baseline characteristics of a clinical trial for prevention of atherosclerosis in patients with insulin-treated type 2 diabetes mellitus using DPP-4 inhibitor: the Sitagliptin Preventive study of Intima-media thickness Evaluation (SPIKE).

Authors:  Tomoya Mita; Naoto Katakami; Toshihiko Shiraiwa; Hidenori Yoshii; Tomio Onuma; Nobuichi Kuribayashi; Takeshi Osonoi; Hideaki Kaneto; Keisuke Kosugi; Yutaka Umayahara; Tsunehiko Yamamoto; Kazunari Matsumoto; Hiroki Yokoyama; Mamiko Tsugawa; Masahiko Gosho; Iichiro Shimomura; Hirotaka Watada
Journal:  Diabetol Metab Syndr       Date:  2014-03-10       Impact factor: 3.320

View more
  2 in total

Review 1.  Multifaceted Mechanisms of Action of Metformin Which Have Been Unraveled One after Another in the Long History.

Authors:  Hideaki Kaneto; Tomohiko Kimura; Atsushi Obata; Masashi Shimoda; Kohei Kaku
Journal:  Int J Mol Sci       Date:  2021-03-05       Impact factor: 5.923

Review 2.  Unexpected Pleiotropic Effects of SGLT2 Inhibitors: Pearls and Pitfalls of This Novel Antidiabetic Class.

Authors:  Hideaki Kaneto; Atsushi Obata; Tomohiko Kimura; Masashi Shimoda; Tomoe Kinoshita; Taka-Aki Matsuoka; Kohei Kaku
Journal:  Int J Mol Sci       Date:  2021-03-17       Impact factor: 5.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.